Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 2671267)

Published in J Neurol Sci on July 01, 1989

Authors

P A Sillevis Smitt1, J M de Jong

Author Affiliations

1: Department of Neurology, University of Amsterdam, The Netherlands.

Articles by these authors

The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53

Muscular changes in the guinea pig caused by chronic ascorbic acid deficiency. J Neurol Sci (1991) 1.37

Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18

Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16

Phosphatidylethanolamine mediates insertion of the catalytic domain of leader peptidase in membranes. FEBS Lett (1998) 1.04

Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol (1995) 1.00

Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99

Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol (1998) 0.98

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol (2013) 0.98

T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97

Ataxia and nystagmus induced by injection of local anesthetics in the Neck. Ann Neurol (1977) 0.96

Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol (1983) 0.96

A prospective longitudinal study on radiation-induced hearing loss. Am J Surg (1994) 0.94

Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope (1999) 0.89

Midsagittal pontomedullary brain stem section: effects on ocular adduction and nystagmus. Exp Neurol (1980) 0.87

Postural and oculomotor signs in labyrinthine-defective subjects. Acta Otolaryngol Suppl (1984) 0.85

Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol (1999) 0.84

Somatosensory compensation for loss of labyrinthine function. Acta Otolaryngol (1984) 0.84

Proposal for a new nomenclature of some well-known clinical syndromes. Clin Neurol Neurosurg (1975) 0.83

Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance. Int J Radiat Oncol Biol Phys (1999) 0.82

Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1992) 0.82

Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up. Breast (2001) 0.82

Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation. Br J Radiol (1995) 0.81

Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncol (2000) 0.81

Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells. J Pathol (2001) 0.81

Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy. J Pathol (1998) 0.80

Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis. Arch Neurol (1992) 0.80

Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry (1995) 0.79

Single-dose radiotherapy (6 Gy): palliation in painful bone metastases. Radiother Oncol (1995) 0.79

Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Exp Gerontol (1999) 0.79

Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine. J Nucl Med (1985) 0.79

Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol (1995) 0.79

The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis. Ann Neurol (1998) 0.78

Nystagmus, gaze shift, and self-motion perception during sinusoidal head and neck rotation. Ann N Y Acad Sci (1981) 0.78

Metallothionein in amyotrophic lateral sclerosis. Biol Signals (1995) 0.78

Cervico-vestibular and visuo-vestibular interaction. Self-motion perception, nystagmus, and gaze shift. Acta Otolaryngol (1982) 0.78

Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett (1992) 0.78

A unique case of intracranial metastasis from lung carcinoma. Clin Neurol Neurosurg (1993) 0.77

Localization of metallothionein in the mammalian central nervous system. Biol Signals (1995) 0.77

Management of depression in elderly general practice patients. Scand J Prim Health Care (1994) 0.77

Neuronophagia in the motor cortex in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol (1993) 0.77

Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants. J Neurol Sci (1996) 0.76

Is the chest radiograph a reliable tool in the assessment of tumor response after radiotherapy in nonsmall cell lung carcinoma? Int J Radiat Oncol Biol Phys (1998) 0.75

Brain gangliosides in the presenile dementia of Pick. J Neurol Neurosurg Psychiatry (1986) 0.75

Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy. Mutat Res (1999) 0.75

Squamous carcinoma of the adolescent larynx. Ear Nose Throat J (1981) 0.75

Temporal lobe pathology in amyotrophic lateral sclerosis. Do amyotrophic lateral sclerosis and Alzheimer's disease share a common etiological factor? Clin Neuropathol (1993) 0.75

[Histopathological and enzyme histochemical studies on experimentally induced muscular dystrophy in the rabbit]. Ned Tijdschr Geneeskd (1968) 0.75

Effects of cross-innervation and disuse on the twitch speed of fast and slow hindlimb muscles in the decerebellate cat. Brain Res (1982) 0.75

Cerebral blood flow imaging with thallium-201 diethyldithiocarbamate SPECT. J Nucl Med (1987) 0.75

Aberrant myelinated neurites in the anterior horns of a patient with amyotrophic lateral sclerosis. Clin Neuropathol (1989) 0.75

DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy. Gynecol Oncol (1994) 0.75

Plasma creatine phosphokinase study in thyroidectomized rabbits and effect of thyroxine and analogues. Biochem Pharmacol (1966) 0.75

Squamous carcinoma of the nasal vestibule. Clin Otolaryngol Allied Sci (1981) 0.75

Uptake of triiodothyronine into cultured human muscle cells. Acta Endocrinol (Copenh) (1983) 0.75

Mortality risk stratification in amyotrophic lateral sclerosis. J Neurol Sci (1995) 0.75

Apoptosis in ALS is not restricted to motoneurons: Bcl-2 expression is increased in post-central cortex, adjacent to the affected motor cortex. J Neurol Sci (1995) 0.75

A study of ureteric peristalsis using a single catheter to record EMG, impedance, and pressure changes. Tech Urol (1999) 0.75

Evidence against increased oxidative stress in fibroblasts from patients with non-superoxide-dismutase-1 mutant familial amyotrophic lateral sclerosis. J Neurol Sci (1996) 0.75

[Histological and autoradiographic study of a physiological form of muscular dystrophy and spinal muscular dystrophy using 125 I labelled thyroid hormone]. Ned Tijdschr Geneeskd (1972) 0.75

Primary hypothyroidism as a complication after treatment of tumours of the head and neck. Acta Radiol Oncol (1982) 0.75

A cerebellar influence upon extrafusal muscle fibers. Agressologie (1973) 0.75

Muscle and central nervous system metamorphosis. Histology and autoradiography. Arch Neurol (1973) 0.75

Free-energy carriers in human cultured muscle cells. Muscle Nerve (1985) 0.75

Fisher's syndrome associated with human immunodeficiency virus infection. Clin Neurol Neurosurg (1990) 0.75

Motor activity and muscle properties in the hemidecerebellate cat. Brain (1983) 0.75

A dystrophy-like myopathy in thyroidectomized rabbits. J Neurol Sci (1969) 0.75

Kinins in ant venoms--a comparison with venoms of related Hymenoptera. Comp Biochem Physiol C (1989) 0.75

[History of healing; bath treatment as psychiatric therapy (1900-1950)]. Ned Tijdschr Geneeskd (1997) 0.75

Baseline assessments in amyotrophic lateral sclerosis trials. J Neurol Sci (1995) 0.75

Autosomal recessive paraparesis with amyotrophy of the hands and feet. Acta Neurol Scand (1993) 0.75

Attempted treatment of motor neuron disease with N-acetylcysteine and dithiothreitol. Adv Exp Med Biol (1987) 0.75

The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy. Radiother Oncol (1995) 0.75